Brain Cancer Cells Switch Migration Routes in Days, AI Tracking Reveals
Researchers at Uppsala University developed GlioTrace, combining automated microscopy and machine learning to track thousands of glioblastoma cells in living mouse brain slices for up to five days, revealing that individual tumor cells can switch migration modes — such as moving along blood vessels then invading tissue — and respond differently to drugs, offering new insights into treatment resistance.
After Tumor Removal, the Challenge Remains
Glioblastoma is one of the most aggressive brain cancers. Its difficulty lies in the ability of cancer cells to infiltrate surrounding healthy brain tissue. Even after surgical removal of the primary tumor, scattered cancer cells may remain and drive recurrence.
Understanding how these cells spread has traditionally relied on single-time-point images. Such snapshots show where cells are but cannot reconstruct how they arrived there or what changes occurred along the way.
The Uppsala University team developed a new method, GlioTrace , which combines automated microscopy with machine learning to continuously track individual cancer cells in brain tissue. The results were published in Nature Communications , providing a new window into the invasion process of glioblastoma.
Tumor Cells from Six Patients, Tracked for Up to Five Days
Researchers collected glioblastoma cells from six patients and implanted them in mouse brains to form tumors. The mouse brains were then sliced into thin sections, kept alive in the lab, and imaged at intervals of no more than two hours for up to five days .
A computational system identified and tracked single tumor cells from the images, while statistical models determined when cells switched between different states. Unlike methods limited to small regions, GlioTrace uses conventional microscopes to monitor cells across the entire brain slice.
Co-first author Hitesh Mangukiya, a researcher at Uppsala University's Department of Immunology, Genetics and Pathology, noted that this approach lets researchers observe how dissemination unfolds in living brain tissue and enables comparison of tumors from different patients and their responses to therapy.
Continuous observation revealed clear inter-patient differences: some patient-derived tumors favored spreading along blood vessels, while others dispersed more into the surrounding brain tissue. Even a single cancer cell could first move along a vessel, then leave it and continue migrating independently through the tissue.
Cancer Cells Switch Paths; Drug Effects Also Vary
Some cells changed their shape and motility patterns within just a few days, demonstrating that cancer cell behavior is far more flexible than static images suggest and does not follow a single fixed route.
Co-first author Madeleine Skeppås, a PhD student at Uppsala University, said this flexibility was the most surprising finding. Developing therapies that stop cancer cell spread requires understanding how they switch between behaviors.
The team used GlioTrace to observe how treatments affect cell movement. In experiments, two drug substances reduced tumor cell movement and spread in brain slices, but the magnitude of the effect varied depending on the patient-derived tumor ; even under identical conditions, cells with different motility patterns responded inconsistently to the drugs.
In another experiment, researchers found that in some tumor models, combined radiotherapy and chemotherapy increased the proportion of cells with a specific morphology. These cells were among the fastest movers and occupied a central position in the network of transitions between cell states, indicating a close link to behavioral changes.
This does not prove that treatment makes cancer cells more aggressive or that these cells necessarily cause recurrence. The study suggests that certain highly invasive cells may persist during treatment, but whether they are more treatment-resistant or participate in tumor relapse requires further validation.
Seeing the Spread Process: How Far from Guiding Therapy?
A key component of GlioTrace is a computational analysis system developed by Skeppås with colleagues at Chalmers University of Technology and the University of Gothenburg. It processes microscopy images, identifies different cancer cell morphologies, and estimates how these features change over time.
The software has been made freely available to researchers for studying how tumor cells interact with their microenvironment and respond to potential treatments. Professor Sven Nelander of Uppsala University's Integrated Cancer Research noted that tracking thousands of individual tumor cells and watching their behavior adjust in real time opens new possibilities for understanding invasion and, in the long term, finding ways to block it.
However, GlioTrace remains a laboratory research method and cannot yet be used to guide clinical treatment decisions for patients. Mangukiya emphasized that the team aims to discover therapies that prevent cancer cells from spreading in the brain, but more research is needed before clinical application.
Editor's Observation: The value of this study lies in showing that cancer cells not only move but also switch between different migration modes. For efforts to block tumor invasion, assessing whether a treatment can limit one dissemination path may be insufficient; whether cells can take an alternative route deserves continuous tracking.
Source: SciTechDaily, original link: https://scitechdaily.com/a-five-day-experiment-reveals-a-surprising-secret-of-deadly-brain-cancer/
Signed-in readers can open the original source through BestHub's protected redirect.
This article has been distilled and summarized from source material, then republished for learning and reference. If you believe it infringes your rights, please contactand we will review it promptly.
How this landed with the community
Was this worth your time?
0 Comments
Thoughtful readers leave field notes, pushback, and hard-won operational detail here.
